Back to Search
Start Over
Impact of preoperative opioid use on patient-reported outcomes following primary total knee arthroplasty.
- Source :
- European Journal of Orthopaedic Surgery & Traumatology; May2023, Vol. 33 Issue 4, p1283-1290, 8p
- Publication Year :
- 2023
-
Abstract
- Purpose: The previous literature suggests that 25–30% of patients who undergo total knee arthroplasty (TKA) are using opioids prior to their surgery. This study aims to investigate the effect of preoperative opioid use on clinical outcomes and patient-reported outcome measures (PROMs) following TKA. Methods: We retrospectively reviewed 329 patients who underwent primary TKA from 2019 to 2020, answered the preoperative opioid survey, and had available PROMs. Patients were stratified into two groups based on whether they were taking opioids preoperatively or not: 26 patients with preoperative opioid use (8%) and 303 patients without preoperative opioid use (92%) were identified. Demographics, clinical data, and PROMs [Forgotten Joint Score (FJS-12), Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR), and Veterans RAND-12 Physical and Mental components (VR-12 PCS and MCS)] were collected. Demographic differences were assessed with Chi-square and independent sample t-tests. Outcomes were compared using multilinear regression analysis, controlling for demographic differences. Results: Preoperative opioid users had a significantly longer length-of-stay (2.74 vs. 2.10; p = 0.010), surgical time (124.65 vs. 105.69; p < 0.001), and were more likely to be African-American (38.5 vs. 14.2%; p = 0.010) compared to preoperative opioid-naive patients. Postoperative FJS-12 did not statistically differ between the two groups. While preoperative KOOS, JR scores were significantly lower for preoperative opioid users (41.10 vs. 46.63; p = 0.043), they did not significantly differ postoperatively. Preoperative VR-12 PCS did not statistically differ between the groups; however, both 3-month (33.87 vs. 38.41; p = 0.049) and 1-year (36.01 vs. 44.73; p = 0.043) scores were significantly lower for preoperative opioid users. Preoperative VR-12 MCS was significantly lower for preoperative opioid users (46.06 vs. 51.06; p = 0.049), though not statistically different postoperatively. Conclusion: At 8%, our study population had a lower percentage of opioid users than previously reported in the literature. Preoperative opioid users had longer operative times and length of stay compared to preoperatively opioid-naive patients. While both cohorts achieved similar clinical benefits following TKA, preoperative opioid users reported lower postoperative scores with respect to VR-12 PCS scores. Level III Evidence: Retrospective Cohort. [ABSTRACT FROM AUTHOR]
- Subjects :
- THERAPEUTIC use of narcotics
LENGTH of stay in hospitals
TOTAL knee replacement
PREOPERATIVE period
HEALTH outcome assessment
RETROSPECTIVE studies
ACQUISITION of data
REGRESSION analysis
TREATMENT duration
HEALTH status indicators
MENTAL health
TREATMENT effectiveness
T-test (Statistics)
MEDICAL records
DESCRIPTIVE statistics
CHI-squared test
QUESTIONNAIRES
AFRICAN Americans
EVALUATION
Subjects
Details
- Language :
- English
- ISSN :
- 16338065
- Volume :
- 33
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- European Journal of Orthopaedic Surgery & Traumatology
- Publication Type :
- Academic Journal
- Accession number :
- 163295678
- Full Text :
- https://doi.org/10.1007/s00590-022-03297-w